Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sathya Venkataramani"'
Autor:
Bharathikumar Vellalore Maruthachalam, Adam Zwolak, Xiefan Lin-Schmidt, Edward Keough, Ninkka Tamot, Sathya Venkataramani, Brian Geist, Sanjaya Singh, Rajkumar Ganesan
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
Mucosal immunity is dominated by secretory IgA and IgM, although these are less favorable compared to IgG molecules for therapeutic development. Polymeric IgA and IgM are actively transported across the epithelial barrier via engagement of the polyme
Externí odkaz:
https://doaj.org/article/cc4b8f1cd804465a927601f8505a713a
Autor:
Sanjaya Singh, Rajkumar Ganesan, Iqbal S. Grewal, Sathya Venkataramani, Jun Chen, Christine Prokopowitz, Ninkka Tamot, Bharathikumar Vellalore Maruthachalam, Paul B. Harvilla, Yonghai Li, M. Jack Borrok
The success of chimeric antigen receptor (CAR) T-cell therapy against hematologic malignancies has altered the treatment paradigm for patients with these diseases. Nevertheless, the occurrence of relapse due to antigen escape or heterogeneous antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ebc4bb4bbad7141533cec8c0952379
https://doi.org/10.1158/2767-9764.c.6550719
https://doi.org/10.1158/2767-9764.c.6550719
Autor:
Cassandra Lowenstein, Subhasree Basu, Joshua Rusbuldt, Sathya Venkataramani, Robin Ernst, Steve Jarantow, Scott Brodeur, Daniel Rubio, Pharavee Jasiprasart, Margaret Yu, Brent Rupnow, Michael Russell
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::497b14e282368728449c391086461905
https://doi.org/10.1136/jitc-2022-sitc2022.1360
https://doi.org/10.1136/jitc-2022-sitc2022.1360
Autor:
Subhasree Basu, Mike Russell, Katrin Sproesser, Bethany Mattson, Cassandra L. Lowenstein, Sathya Venkataramani, Maura Diamond, Robin E. Ernst, Stephen Jarantown, Jackson Wong, Gerald Chu, Kathryn Packman, Shaozhou Ken Tian, Scott R. Brodeur, Margaret Yu, Brent A. Rupnow
Publikováno v:
Cancer Research. 82:LB087-LB087
TMEFF2, a transmembrane protein with epidermal growth factor-like and 2 follistatin-like domains, is primarily restricted in expression to healthy brain and prostate and is enriched in prostate cancer. JNJ-70218902 (JNJ-902) is a bispecific antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2980c9759af2a1a5e7a0c3a0c62cc9b
https://doi.org/10.1158/1538-7445.am2022-lb087
https://doi.org/10.1158/1538-7445.am2022-lb087